Medicare Enrolled

Dr. Shyam Khanwani, MD

Hematology & Oncology · Fayetteville, GA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Consulting-driven
132 OLD NORTON RD STE 200, Fayetteville, GA 30215
6788171117
In practice since 2006 (20 years)
NPI: 1184602856 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Khanwani from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Khanwani? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Khanwani

Dr. Shyam Khanwani is a hematology & oncology specialist in Fayetteville, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Khanwani performed 680 Medicare services across 429 unique beneficiaries.

Between the years covered by Open Payments, Dr. Khanwani received a total of $23,170 from 37 pharmaceutical and/or device companies across 111 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Khanwani is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 680 Medicare services $23,170 industry payments

Medicare Practice Summary

Medicare Utilization ↗
680
Medicare services
Bottom 49% in GA for hematology & oncology
429
Unique beneficiaries
$58
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~34 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
328 $48 $213
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
167 $75 $314
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
56 $63 $210
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
28 $95 $484
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
27 $40 $115
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
22 $23 $129
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
20 $63 $317
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
20 $104 $400
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
12 $37 $228
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$23,170
Total received (2018-2024)
Avg $3,862/year across 6 years
Top 17% in GA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
111
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$15,431 (66.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$5,565 (24.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,174 (9.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$5,031
2023
$12,536
2022
$3,737
2021
$109
2020
$1,688
2018
$69

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ADC Therapeutics America, Inc.
$2,418
AstraZeneca Pharmaceuticals LP
$1,200
ABBVIE INC.
$172
Celgene Corporation
$132
Janssen Biotech, Inc.
$127
Gilead Sciences, Inc.
$124
Novartis Pharmaceuticals Corporation
$121
PFIZER INC.
$89
Genentech USA, Inc.
$80
Janssen Scientific Affairs, LLC
$74
Merck Sharp & Dohme LLC
$72
GENZYME CORPORATION
$57
Daiichi Sankyo Inc.
$49
Lilly USA, LLC
$41
Alexion Pharmaceuticals, Inc.
$37
Pharmacosmos Therapeutics Inc.
$36
GlaxoSmithKline, LLC.
$29
BeiGene USA, Inc.
$27
Takeda Pharmaceuticals U.S.A., Inc.
$27
SOBI, INC
$25
Deciphera Pharmaceuticals Inc.
$22
Tempus AI, Inc
$20
Acrotech Biopharma Inc.
$19
Exelixis Inc.
$16
TAIHO ONCOLOGY, INC.
$15
Top 3 companies account for 75.3% of 2024 payments
All-time payments by company (2018-2024) ›
Kite Pharma, Inc.
$10,126
Shield Therapeutics Inc
$4,831
ADC Therapeutics America, Inc.
$2,433
Celgene Corporation
$1,820
AstraZeneca Pharmaceuticals LP
$1,200
Gilead Sciences, Inc.
$304
Alexion Pharmaceuticals, Inc.
$299
Novocure GmbH
$200
ABBVIE INC.
$172
Foundation Medicine, Inc.
$163
Lilly USA, LLC
$162
Regeneron Healthcare Solutions, Inc.
$150
GT Medical Technologies, Inc
$140
Janssen Biotech, Inc.
$127
Novartis Pharmaceuticals Corporation
$121
Merck Sharp & Dohme LLC
$95
PFIZER INC.
$89
Genentech USA, Inc.
$80
Daiichi Sankyo Inc.
$77
Janssen Scientific Affairs, LLC
$74
GENZYME CORPORATION
$57
Takeda Pharmaceuticals U.S.A., Inc.
$50
GlaxoSmithKline, LLC.
$47
BeiGene USA, Inc.
$47
Deciphera Pharmaceuticals Inc.
$41
Bayer HealthCare Pharmaceuticals Inc.
$38
Pharmacosmos Therapeutics Inc.
$36
SOBI, INC
$25
Eisai Inc.
$25
Astellas Pharma US Inc
$22
Incyte Corporation
$21
Tempus AI, Inc
$20
Coherus Biosciences Inc.
$20
Acrotech Biopharma Inc.
$19
Exelixis Inc.
$16
TAIHO ONCOLOGY, INC.
$15
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$7
Top 3 companies account for 75.1% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · Alecensa · Aliqopa · BELEODAQ · BRUKINSA · CABOMETYX · CALQUENCE · DARZALEX · DOPTELET · ELAHERE · EPKINLY · ERLEADA · Enhertu · Fabhalta · GAMMATILE · IBRANCE · INJECTAFER · INLYTA · JAKAFI · JEMPERLI · KEYTRUDA · KISQALI · LIBTAYO · LONSURF · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · LifeVest · MONOFERRIC · NINLARO · OJJAARA · PADCEV · PLUVICTO · Padcev · Phesgo · Pomalyst · QINLOCK · REBLOZYL · RYBREVANT · Rituxan · SARCLISA · SOLIRIS · TECVAYLI · TIVDAK · Trodelvy · ULTOMIRIS · Udenyca · VERZENIO · Venclexta · Yescarta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (67%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.

Looking for a hematology & oncology specialist in Fayetteville?
Compare hematology & oncology specialists in the Fayetteville area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
34
Per 100K population
28.2
County median income
$108,986
Nearest hospital
PIEDMONT FAYETTE HOSPITAL
7.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Khanwani is a clinical cardiology specialist, with moderate Medicare volume, with consulting-driven industry engagement in the top 17% of GA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Khanwani experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Khanwani performed 328 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Khanwani receive payments from pharmaceutical companies?
Yes. Dr. Khanwani received a total of $23,170 from 37 companies across 111 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Khanwani's costs compare to other hematology & oncology specialists in Fayetteville?
Dr. Khanwani's average Medicare payment per service is $58. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Khanwani) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →